33 "Batra Sandeep, Md" clinical studies found.

• PHO-COG-FALLON-ANBL00B1; Neuroblastoma Biology Studies

  This research trial studies biomarkers in tumor tissue samples from patients with newly diagnosed neuroblastoma or ganglioneuroblastoma.

  Batra Sandeep, Md

• Key Adverse Events Following Childhood Cancer

  The goal of this study is to identify subjects who are more likely to develop a late-occurring complication(s) after ...

  Batra Sandeep, Md

• A COG Soft Tissue Sarcoma Biology and Banking Protocol

  The purpose of this study is to better diagnose certain types of cancer.

  Batra Sandeep, Md

• Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 years

  This randomized phase III trial is studying maintenance chemotherapy to see how well it works compared to observation following induction ...

  Batra Sandeep, Md

• Neuropsychological Social Emotional and Behavioral Outcomes in Children with Cancer

  This research trial studies neuropsychological (learning, remembering or thinking) and behavioral testing in younger patients with cancer. Collecting information over ...

  Batra Sandeep, Md

• A Randomized Phase II Trial of Brentuximab Vedotin (SGN35 NSC# 749710) or Crizotinib (NSC#749005 Commercially Labeled) in Combination With ...

  This partially randomized phase II trial studies how well brentuximab vedotin or crizotinib and combination chemotherapy works in treating patients ...

  Batra Sandeep, Md

• A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T- ...

  This randomized phase III clinical trial compares how well combination chemotherapy works when given with or without bortezomib in treating ...

  Batra Sandeep, Md

• Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-high-Risk Neuroblastoma: A Groupwide Historically Controlled Phase III ...

  This phase III trial studies how well response and biology-based risk factor-guided therapy works in treating younger patients with non-high ...

  Batra Sandeep, Md

• Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)

  This randomized phase III trial compares how well blinatumomab works compared with standard combination chemotherapy in treating patients with B-cell ...

  Batra Sandeep, Md

• Randomized Phase II Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479 NSC# 750008) to Multiagent Chemotherapy ...

  This randomized phase II trial studies how well combination chemotherapy with or without ganitumab works in treating patients with newly ...

  Batra Sandeep, Md